CircRNAs: role in human diseases and potential use as biomarkers
L Verduci, E Tarcitano, S Strano, Y Yarden… - Cell death & …, 2021 - nature.com
Circular RNAs (circRNAs) are a class of endogenous RNAs characterized by a covalent
loop structure. In comparison to other types of RNAs, the abundance of circRNAs is relatively …
loop structure. In comparison to other types of RNAs, the abundance of circRNAs is relatively …
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
A Elmusrati, J Wang, CY Wang - International journal of oral science, 2021 - nature.com
Head and neck squamous cell carcinoma (HNSCC), an aggressive malignancy, is
characterized by high morbidity and low survival rates with limited therapeutic options …
characterized by high morbidity and low survival rates with limited therapeutic options …
The molecular landscape of head and neck cancer
CR Leemans, PJF Snijders, RH Brakenhoff - Nature Reviews Cancer, 2018 - nature.com
Head and neck squamous cell carcinomas (HNSCCs) arise in the mucosal linings of the
upper aerodigestive tract and are unexpectedly heterogeneous in nature. Classical risk …
upper aerodigestive tract and are unexpectedly heterogeneous in nature. Classical risk …
Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
H Chi, J Yang, G Peng, J Zhang, G Song, X Xie… - Frontiers in …, 2023 - frontiersin.org
Background Head and neck squamous cell carcinoma (HNSCC) is the most common head
and neck cancer and is highly aggressive and heterogeneous, leading to variable prognosis …
and neck cancer and is highly aggressive and heterogeneous, leading to variable prognosis …
The multidisciplinary team (MDT) approach and quality of care
M Taberna, F Gil Moncayo, E Jané-Salas… - Frontiers in …, 2020 - frontiersin.org
The core function of a multidisciplinary team (MDT) is to bring together a group of healthcare
professionals from different fields in order to determine patients' treatment plan. Most of head …
professionals from different fields in order to determine patients' treatment plan. Most of head …
Immunotherapy for head and neck cancer: Recent advances and future directions
JD Cramer, B Burtness, RL Ferris - Oral oncology, 2019 - Elsevier
Three randomized phase III trials have now conclusively proven that exposure to a PD-1
inhibitor prolongs survival in recurrent/metastatic (R/M) HNSCC, and it is clear that such …
inhibitor prolongs survival in recurrent/metastatic (R/M) HNSCC, and it is clear that such …
miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses
HA El-Mahdy, AM Mohamadin, AI Abulsoud… - … -Research and Practice, 2023 - Elsevier
Head and neck cancers (HNCs) are a group of heterogeneous tumors formed most
frequently from epithelial cells of the larynx, lips, oropharynx, nasopharynx, and mouth …
frequently from epithelial cells of the larynx, lips, oropharynx, nasopharynx, and mouth …
Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment
S Marur, AA Forastiere - Mayo Clinic Proceedings, 2016 - Elsevier
Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck
region. The risk factors for development of cancers of the oral cavity, oropharynx …
region. The risk factors for development of cancers of the oral cavity, oropharynx …
Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5
X Qin, H Guo, X Wang, X Zhu, M Yan, X Wang, Q Xu… - Genome biology, 2019 - Springer
Background Cisplatin resistance is a major challenge for advanced head and neck cancer
(HNC). Understanding the underlying mechanisms and developing effective strategies …
(HNC). Understanding the underlying mechanisms and developing effective strategies …
Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma
DW Zheng, WW Deng, WF Song, CC Wu… - Nature biomedical …, 2022 - nature.com
Because a host's immune system is affected by host–microbiota interactions, means of
modulating the microbiota could be leveraged to augment the effectiveness of cancer …
modulating the microbiota could be leveraged to augment the effectiveness of cancer …